Psychiatr. pro Praxi, 2008; 9(2): 55
Psychiatr. pro Praxi, 2008; 9(2): 60-64
The concept of major psychiatric disorders is not static and changes with the advances of science. Biomarkers including parameters obtained using brain imaging methods will probably play a more important role in the incoming classification. Major psychiatric disorders, recurrent depression, bipolar and schizophrenic disorders are considered life-long diseases which need long-time treatment. They are more or less consistently connected with functional and structural changes in the brain. The disease and its treatment form a process which has its own dynamics which has to be always considered. Acute treatment has different goals than the maintenance...
Psychiatr. pro Praxi, 2008; 9(2): 65-70
Schizoaffective disorder is a common and disabling mental illness. Unfortunately, the pharmacological treatment of this disorder has not been studied adequately. While several studies demonstrate the effectiveness of combined treatment for affective or negative symptoms in schizoaffective disorder, the use of atypical antipsychotics as monotherapy represents an important advance. The article reviewed therapeutic algorithms used in the treatment of schizoaffective disorder.
Psychiatr. pro Praxi, 2008; 9(2): 72-76
The influence of light on human psyche was known and used two thousand years ago by ancient Greeks. The modern development of light treatment and the description of the seasonal affective syndrome were strongly influence by the finding that melatonin in men could be suppressed by bright light. Shortly after this information was published the first placebo-controlled study on light treatment for depression was done. Now bright light therapy or phototherapy has become the mainstay of the treatment of winter type of seasonal affective disorder. Seasonal affective disorder (SAD) is typical manifestation of seasonality in humans. It is characterized by...
Psychiatr. pro Praxi, 2008; 9(2): 77-79
Multiple sclerosis (MS) is a threatening disease for the ill with virtually interminable variability of symptoms. Many MS symptoms directly or indirectly influence negatively male sexuality. Sexual disorders in MS are present in 65–90 % of cases. Among them, erectile dysfunction, decreased sexual desire, problems in completing orgasm and decreased tactile sensitivity prevail. The treatment of sexual dysfunction in MS must be based on teamwork; the team being formed by neurologists, urologists, psychiatrists, psychologists and sexologists. The article deals with treatment possibilities of particular most frequent sexual dysfunctions in males...
Psychiatr. pro Praxi, 2008; 9(2): 80-82
Psychiatr. pro Praxi, 2008; 9(2): 83
Psychiatr. pro Praxi, 2008; 9(2): 84-85
Psychiatr. pro Praxi, 2008; 9(2): 96
Psychiatr. pro Praxi, 2008; 9(2): 86-88
Psychiatr. pro Praxi, 2008; 9(2): 89-90
Psychiatr. pro Praxi, 2008; 9(2): 91-92
Psychiatr. pro Praxi, 2008; 9(2): 97-98
Psychiatr. pro Praxi, 2008; 9(2): 93-95